Slovakia Health Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Clinical Trials
• Forums

Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer
Condition:   Testicular Cancer Interventions:   Drug: Veliparib;   Drug: Gemcitabine;   Drug: Carboplatin Sponsor:   National Cancer Institute, Slovakia Recruiting - verified August 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2016 Category: Research Source Type: clinical trials